Download PDF
Thromb Haemost 1985; 53(02): 264-267
DOI: 10.1055/s-0038-1661290
Original Article
Schattauer GmbH Stuttgart

Incorporation of Some Eicosaenoic Acids into Endothelial Cells – Effect on Platelet Inhibitory Activity and Prostacyclin Production

Béatrice Sicard
The Institut Pasteur, INSERM U.63 and Laboratoire d’Hémobiologie, Faculté de Médecine Alexis Carrel, Lyon, France
,
Michel Lagarde
The Institut Pasteur, INSERM U.63 and Laboratoire d’Hémobiologie, Faculté de Médecine Alexis Carrel, Lyon, France
› Author Affiliations
Further Information

Publication History

Received 09 November 1984

Accepted 05 February 1985

Publication Date:
18 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Primary cultures of endothelial cells from human umbilical veins were grown until confluency. Then, dihomogammalinolenic acid (DHLA or 20:3n-6) and eicosapentaenoic acid (EPA or 20:5n-3), precursors of monoenoic and trienoic prostanoids, respectively, as well as 5,8,11-eicosatrienoic acid (20:3n-9), and isomer of DHLA, were incorporated into endothelial lipids. DHLA-rich endothelial cells had a decreased capacity of prostacyclin production. By contrast EPA- or 20:3n-9-rich endothelial cells were comparable to controls in this respect. DHLA and EPA were efficiently acylated into cell phospholipids and triglycerides at the opposite of 20:3n-9. It is suggested that both DHLA and EPA could alter the liberation of endogenous arachidonic acid for prostacyclin synthesis but this might be counterbalanced in EPA-rich endothelial cells by PGI3 production. We conclude that DHLA enrichment of endothelial cell lipids may impair the possible beneficial effect of the acid upon platelet functions whereas that of EPA would not be modified.

Keywords

Endothelial cells - Prostacyclie - Platelet inhibitory activity - Eicosaenoic acids
 

  • References

  • 1 Moncada S, Herman AG, Higgs EA, Vane JR. Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium Thrombos Res 1977; 11: 323-344
    CrossrefPubMedGoogle Scholar
  • 2 Moncada S, Vane JR. The role of PGI2 in vascular tissue. Fed Proc 1979; 38: 66-71
    PubMedGoogle Scholar
  • 3 Moncada S, Gryglewski R, Bunting S, Vane JR. An enzyme isolated form arteries transformed prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976; 263: 663-665
    CrossrefPubMedGoogle Scholar
  • 4 Salmon J, Smith D, Flower R, Moncada S, Vane JR. Further studies on the enzymatic conversion of prostaglandin endoperoxides into prostacyclin by porcine aorta microsomes. Biochim Biophys Acta 1978; 523: 250-262
    CrossrefPubMedGoogle Scholar
  • 5 Willis AL. Nutritional and pharmacological factors in eicosanoid biology. Nutr Rev 1981; 39: 289-301
    PubMedGoogle Scholar
  • 6 Goodnight SH, Harris WS, Connor WE, Illingworth DR. Polyunsaturated fatty acids, hyperlipidemia, and thrombosis. Arteriosclerosis 1982; 2: 87-113
    CrossrefPubMedGoogle Scholar
  • 7 Silver MJ, Smith JB, Ingerman CU, Kocsis JJ. Arachidonic acid induced human platelet aggregation and prostaglandin formation. Prostaglandins 1973; 4: 863-875
    CrossrefPubMedGoogle Scholar
  • 8 Lagarde M, Guichardant M, Dechavanne M. Human platelet PGE1 and dihomogammalinolenic acid Comparison to PGE2 and arachidonic acid. Progr Lipid Res 1981; 20: 439-443
    CrossrefPubMedGoogle Scholar
  • 9 Renaud S, Dumont E, Godsey F, Morazain R, McGregor L. Effects of diet on blood clotting and platelet aggregation. In nutrition in the 1980s. Alan R Liss; New York: 1981. pp 361-381
    Google Scholar
  • 10 Lagarde M, Burtin M, Sprecher H, Dechavanne M, Renaud S. Potentiating effect of 5,8,11-eicosatrienoic acid on human platelet aggregation. Lipids 1981; 18: 291-294
    PubMedGoogle Scholar
  • 11 Nordoy A, Svensson B, Hoak J. The effects of albumin bound fatty acids on the platelet inhibitory function of human endothelial cells. Eur J Clin Invest 1979; 9: 5-10
    CrossrefPubMedGoogle Scholar
  • 12 Nordoy A, Svensson B. The simultaneous effect of albumin bound fatty acids on platelets and endothelial cells. Thrombos Res 1979; 15: 215-226
    CrossrefPubMedGoogle Scholar
  • 13 Lagarde M, Burtin M, Dechavanne M, Sicard B, Coiffier B. Dihomogammalinolenic acid (20 3ω6) is more anti-aggregatory than eicosapentaenoic (20 5ω3) in a platelet endothelial cell mixture. Prostaglandins Med 1980; 4: 177-183
    CrossrefPubMedGoogle Scholar
  • 14 Brox JH, Nordoy A. The effect of polyunsaturated fatty acids on endothelial cells and their production of prostacyclin, thromboxane and platelet inhibitory activity. Thromb Haemostas 1983; 50: 762-767
    PubMedGoogle Scholar
  • 15 Spector AA, Kaduce TL, Figard PH, Norton KC, Hoak JC, Czervionke RL. Eicosapentaenoic acid and prostacyclin production by cultured human endothelial cells. J Lipid Res 1983; 24: 1595-1604
    PubMedGoogle Scholar
  • 16 Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic arteria J Clin Invest 1973; 52: 2745-2756
    CrossrefPubMedGoogle Scholar
  • 17 Lagarde M, Sicard B, Guichardant M, Felisi O, Dechavanne M. Fatty acid composition in native and cultured human endothelial cells. In vitro 1984; 20: 33-37
    CrossrefPubMedGoogle Scholar
  • 18 Lagarde M, Drouot B, Guichardant M, Dechavanne M. In vitro incorporation and metabolism of some icosaenoic acids in platelets. Effect on arachidonic acid oxygenation Biochim Biophys Acta 1985; 833: 52-58
    CrossrefPubMedGoogle Scholar
  • 19 Lagarde M, Bryon PA, Guichardant M, Dechavanne M. A simple and efficient method for platelet isolation from their plasma. Thromb Res 1980; 17: 581-588
    CrossrefPubMedGoogle Scholar
  • 20 Siess W, Dray F. Very low levels of 6-keto prostaglandin F1α in human plasma. J Lab Clin Med 1982; 99: 388-398
    PubMedGoogle Scholar
  • 21 Spector AA, Kaduce TL, Hoak JC, Fry GL. Utilisation of arachidonic and linoleic acids by cultured human endothelial cells. J Clin Invest 1981; 68: 1003-1011
    CrossrefPubMedGoogle Scholar
  • 22 Rosenthal MD, Whitehurst MC. Fatty acyl Δ6 desaturation activity of cultured human endothelial cells modulation by fetal bovine serum. Biochim Biophys Acta 1983; 750: 490-496
    CrossrefPubMedGoogle Scholar
  • 23 Croset M, Lagarde M. Stereospecific inhibition of PGH2 induced platelet aggregation by lipoxygenase products of icosaenoic acids. Biochem Biophys Res Commun 1983; 112: 878-883
    CrossrefPubMedGoogle Scholar
  • 24 Brotherton AA, Hoak JC. Prostacyclin biosynthesis in cultured vascular endothelium is limited by deactivation of cyclooxygenase. J Clin Invest 1983; 72: 1255-1261
    CrossrefPubMedGoogle Scholar
  • 25 Thomas JM, Hullen F, Chap H, Douste-Blazy L. Phosphatidyl choline is the major phospholipid providing arachidonic acid for prostacyclin synthesis in thrombin stimulated human endothelial cells. Thromb Res 1984; 34: 117-123
    CrossrefPubMedGoogle Scholar
  • 26 Dyerberg J, Jorgensen KA, Arnfred T. Human umbilical blood vessel converts all cis 5,8,11,14,17-eicosapentaenoic acid to prostaglandin I3 . Prostaglandins 1981; 22: 857-862
    CrossrefPubMedGoogle Scholar
  • 27 Homstra G, Christ-Hazelhof E, Haddeman E, Ten HoorF, Nugteren DH. Fish oil feeding lowers thromboxane and prostacyclin production by rat platelets and aorta and does not result in the formation of prostaglandin I3 . Prostaglandins 1981; 21: 727-738
    CrossrefPubMedGoogle Scholar
  • 28 Fischer S, Weber PC. Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acid. Nature 1984; 307: 165-168
    CrossrefPubMedGoogle Scholar
  • 29 Denning GM, Figard PH, Kaduce TL, Spector AA. Role of triglycerides in endothelial cell arachidonic metabolism. J Lipid Res 1983; 24: 993-1001
    PubMedGoogle Scholar